SRMC - Department of Chest & TB

S.No	Name of Project	Company Name	Start of study	Completion of study
1.	A Multicentre , Randomized, Double-Blind, Double Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the treatment of mild to moderate Community Acquired pneumonia in Adutls. Protocol A0661103.	Pfizer	23/7/2003	Completed
2.	Multi center, Multinational, Randomized, double blind, placebo controller trial to assess the effect of Study Drug modified release 100mg (UK-369,003) on exercise capacity in subjects with Pulmonary hypertension associated COPD Protocol no.3711028	Pharma Net	11-1-2005	1/4/2005
3.	A randomized, double-blind, multicentre, parallel-group, safety and efficacy study comparing two ipratropium /salbutamol(20microgram/100microgram per actuation) formulations delivered by pressurized metered dose inhaler impratropium/salbutamol CFC pMDI vs impratropium/salbutamol HFA pMDI), administered for 12 weeks in adult patients with chronic obstructive pulmonary disease(COPD) Protocol : No CP/03/04	Lambda	22-11-05	19/10/06
4.	A pivotal Open label, parallel study to Evaluate the safety and efficacy of Human insulin inhalation powder(HIIP) compared to injectable insulin in patient with DM and COPD or Asthma Protocol H7U-MC-IDAS	Eli Lilly & Company	06-10-05
5.	Drug trial - Efficacy and Safty of CFC-Free Formulation of Budesonide Compared with The Reference CFC Formulation in Patients with Asthma: A Randomised, Multicentre, Double Blind Trial in Parallel Groups Of Patients with Presistent Moderate Asthma Protocol No: CT/01/06	Chiltern	23/9/06
6.	Title of the trial : A Randomised , Double – blind , Placebo- controlled. Parallel group to assess long term (one year ) efficacy and safety of tiotropium Inhalation solution 5mcg ( 2.5 mcg ) Delivered by the Respimat Inhaler in Patients with Chronic Obstructive Pulmonary Disease. Trial No : 205.372	SiroIndia	Aug -2006	Jan 2009
7.	Multi – centric study on Prevalance of Asthma	Indian Council of Medical Research	Sep-2006
8.	P04073- A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared with Mometasone Furoate and Formoterol Monotherapy in Subjects with Persistent Asthma Previously Treated with Low-Dose Inhaled Glucocorticosteroids	Quintiles Clin Pharm		Not undertaken
9.	P04334-A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared with Mometasone Furoate and Formoterol Monotherapy in Subjects with Persistent Asthma Previously Treated with Medium-Dose Inhaled Glucocorticosteroids	Quintiles Clinical Research		Not undertaken
10.	Protocol P04229 titiled : “A randomized Placebo-Controlled Efficacy and Safety Study of 1 year Treatment duration with high and medium dose inhaled Memetasone Furoate /Formoterol combination formulation compared with formoterol and high dose inhaled Memetasone furoate Monotherapy in subjects with Moderate to Severe COPD”	Quintiles Clinical Research

^ Top